Hepatotoxicity SIG: Drug Induced Liver Injury: Assessing Risk and Predicting Outcome

4.67 (3 votes)

Recorded On: 11/08/2019

Clinicians and translational researchers will glean approaches to assess drug induced liver injury (DILI) risk and predict outcomes at this session. Faculty will review basic hepatic drug metabolism in healthy and diseased livers, strategies to detect DILI during drug treatment and possible DILI risk factors, such as dose, duration, genetics and immunity. They will also share useful databases for clinicians.

Jay H. Hoofnagle
Craig Lammert


Dose, Duration and Drug Characteristics as Risk Factors for Liver Injury
Open to view video.
Open to view video. Presenter: Craig Lammert
Resources to Help the Clinician Manage Hepatotoxicity: Focus on LIVERTOX
Open to view video.
Open to view video. Presenter: Jay H. Hoofnagle
Final Evaluation
Final Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.